Related Experiment Video

Updated: Aug 19, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
09:22

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

Published on: November 4, 2015

Hypoplastic lungs and abnormal phospholipids in asphyxiating thoracic dystrophy

P Forrest, A Harkes, S W D'Souza

    Australian Paediatric Journal
    |February 1, 1987
    PubMed

    Insights

    Asphyxiating thoracic dystrophy may involve hypoplastic lungs with abnormal phospholipid content, impacting respiratory function. This challenges the prior focus solely on rib growth limitations.

    Area of Science:

    • Pediatric Pulmonology
    • Medical Genetics
    • Thoracic Imaging

    Background:

    • Asphyxiating thoracic dystrophy (ATD) respiratory impairment was previously linked to reduced rib growth and chest expansion.
    • The exact pathophysiology of ATD-related respiratory compromise requires further elucidation.

    Observation:

    • Two siblings with ATD presented with distinct respiratory functional deficits.
    • One sibling exhibited low crying vital capacity; the other showed a markedly reduced peak flow rate.
    • Chest X-rays and ventilation-perfusion scans indicated potential lung hypoplasia.

    Findings:

    • Airway secretions in ATD patients had significantly lower total phospholipids.
    • Alterations in phospholipid composition were observed in ATD patients compared to controls.
    • These biochemical findings suggest abnormal lung development and function in ATD.

    Implications:

    • The findings suggest lung hypoplasia and abnormal phospholipid content are key features of ATD.
    • This shifts focus from solely rib cage mechanics to intrinsic lung abnormalities.
    • Further research into lung development and phospholipid metabolism in ATD is warranted.

    More Related Videos

    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

    Published on: March 6, 2019

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

    Published on: October 31, 2025

    Related Concept Videos

    Breathing01:05

    Breathing

    The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
    Acute Respiratory Failure-II01:21

    Acute Respiratory Failure-II

    Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
    The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
    Acute Respiratory Failure-III01:30

    Acute Respiratory Failure-III

    Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
    Pneumothorax II: Pathophysiology01:08

    Pneumothorax II: Pathophysiology

    Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
    Atelectasis II: Pathophysiology01:10

    Atelectasis II: Pathophysiology

    Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
    Chronic Obstructive Pulmonary Disease II: Emphysema01:23

    Chronic Obstructive Pulmonary Disease II: Emphysema

    Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.